A Study for the Evaluation of the Safety, Tolerability, and Efficacy of ARX-F02 (Sufentanil NanoTab) Compared to Placebo in the Treatment of Cancer Breakthrough Pain
Clinical trial NCT00833040 · COMPLETED
Trial details
- NCT number
- NCT00833040
- Sponsor
- Talphera, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2010-03-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.